How many insider declarations has Summit Partners Growth Equity Fund IX-B, L.P. filed?

Summit Partners Growth Equity Fund IX-B, L.P. has filed 2 public insider declarations with SEC (Form 4).

What is Summit Partners Growth Equity Fund IX-B, L.P.'s role?

Summit Partners Growth Equity Fund IX-B, L.P.'s reported role is not specified by the regulator across the filings.

Which companies does Summit Partners Growth Equity Fund IX-B, L.P. report trades for?

Summit Partners Growth Equity Fund IX-B, L.P. reports trades for 2 companies, including LifeStance Health Group, Inc..

← Executives ★ Sign in to follow

SP

Summit Partners Growth Equity Fund IX-B, L.P.

·SEC (Form 4)

LifeStance Health Group, Inc.KLAVIYO, INC

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the detailed record of transactions filed by Summit Partners Growth Equity Fund IX-B, L.P.. Officer active across 2 companies, notably LifeStance Health Group, Inc.. In total, 2 filings have been logged. Activity tracked since 10 August 2026. The latest transaction was filed on 11 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is openly available.

Companies and markets linked to Summit Partners Growth Equity Fund IX-B, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

LifeStance Health Group, Inc. (US)KLAVIYO, INC (US)

申报2 总计

●

Summit Partners Growth Equity Fund IX-B, L.P.

10% Stockholder高管2026年8月11日KLAVIYO, INC

US$3388万0来源 ↗

1,845,131 股@ US$18.36Series A Common stock, par value $0.001 per shareSEC144:0001634426-26-000005

●

Summit Partners Growth Equity Fund IX-B, L.P.

Owner高管2026年8月10日LifeStance Health Group, Inc.

US$1156万24来源 ↗

1,088,162 股@ US$10.620.28% mcap100.0% 占其流量Common StockSEC144:0001634426-26-000003

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

SP

Summit Partners Growth Equity Fund IX-B, L.P.

·SEC (Form 4)

LifeStance Health Group, Inc.KLAVIYO, INC

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the detailed record of transactions filed by Summit Partners Growth Equity Fund IX-B, L.P.. Officer active across 2 companies, notably LifeStance Health Group, Inc.. In total, 2 filings have been logged. Activity tracked since 10 August 2026. The latest transaction was filed on 11 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is openly available.